Načítá se...
Myocardial Infarction: Cardioprotection by Erythropoietin
Extensive research during the last decade demonstrated that a single systemic administration of erythropoietin (EPO) lead to significant attenuation of myocardial infarction (MI) induced in animals, mostly small rodents, either by a myocardial ischemia followed by reperfusion or by a permanent ligat...
Uloženo v:
| Vydáno v: | Methods Mol Biol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6207951/ https://ncbi.nlm.nih.gov/pubmed/23456875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/978-1-62703-308-4_17 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|